{"id":44209,"date":"2022-05-23T14:01:18","date_gmt":"2022-05-23T12:01:18","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/nice-cxone-selected-by-medquest-to-enhance-patient-experiences-with-new-advanced-integrated-digital-and-self-service\/"},"modified":"2022-05-23T14:01:18","modified_gmt":"2022-05-23T12:01:18","slug":"nice-cxone-selected-by-medquest-to-enhance-patient-experiences-with-new-advanced-integrated-digital-and-self-service","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/nice-cxone-selected-by-medquest-to-enhance-patient-experiences-with-new-advanced-integrated-digital-and-self-service\/","title":{"rendered":"NICE CXone Selected by MedQuest to Enhance Patient Experiences with New Advanced Integrated Digital and Self-Service"},"content":{"rendered":"
\n

\nA leader in outpatient imaging services to provide smart digital and self-service experiences with NICE CXone to improve services for patients, health systems and hospitals<\/i>\n<\/p>\n

HOBOKEN, N.J.–(BUSINESS WIRE)–#NICE<\/a>—NICE<\/a> (Nasdaq: NICE) <\/b>today announced that MedQuest Associates, a leading manager of outpatient diagnostic imaging facilities, has selected the NICE CXone Essentials Suite to enrich its services to patients, health systems and hospitals. Implementation of NICE\u2019s world-leading customer experience platform is part of MedQuest\u2019s ongoing investment in improved patient interactions, self-service options and employee effectiveness.\n<\/p>\n

<\/a><\/p>\n

\nMedQuest partners with hospitals and health systems to develop and execute strategies for outpatient radiology, including mobile MRI unit management, women’s imaging services, administration of freestanding imaging networks, patient scheduling, and other aspects of end-to-end radiology workflows. The company operates a network of over 50 imaging centers in the southeastern United States, supported by several contact centers that handle up to a million inbound and outbound interactions annually. With the deployment of NICE CXone Essentials Suite, MedQuest is introducing new process automations, digital channels and self-service options to improve efficiency and patient experience.\n<\/p>\n

\nCXone Essentials include intelligent call routing, outbound dialer automation, support for multichannel interactions, and caller sentiment analytics on a cloud-based platform, which ensures MedQuest stability and high uptime for all its customer support services. The suite also includes a NICE Quality Management solution that incorporates sentiment analysis for targeted employee coaching, regulatory compliance and optimization.\n<\/p>\n

\nIn addition, MedQuest is leveraging the CXone platform to provide patients a secure, self-service format for scheduling imaging appointments for more efficient management and greater customer engagement. For MedQuest employees who are tasked with managing the imaging schedules and sessions and coordinating among patients and affiliated health systems, the CXone Essentials Suite includes Proactive XS. It creates automated dialer lists, which include voice, email and SMS contacts, for issuing the necessary updates, documents, confirmations and other forms of communication with clients. This also allows MedQuest to unify their backend systems into a single platform for more trustworthy data, coherent processes and innovative management solutions.\n<\/p>\n

\n\u201cAt MedQuest, we always strive to improve the quality of service, care and value we provide to patients and to our healthcare partners,\u201d said Serena Gilpin, MPA, Sr. Director, Radiology Patient Services, MedQuest Associates<\/b>. \u201cPart of that commitment, reflected in our history of success in outpatient imaging, is partnering with companies like NICE to improve customer experience with the most sophisticated solutions available. The CXone Essentials Suite is a toolbox for reinventing our patient services, so we can roll out digital channels, introduce automations and provide self-service across our enterprise. Patients can independently manage their imaging appointments, while our employees are better equipped to provide top-notch patient support from start to finish.\u201d\n<\/p>\n

\nAs the most comprehensive suite of solutions available, CXone streamlines billing, automates communications, lowers operating costs and helps to ensure secure communications.\n<\/p>\n

\n\u201cIn the global healthcare sector, customer service and contact centers have seen a massive increase in the volume of interactions in recent years,\u201d said Paul Jarman, NICE CXone CEO<\/b>. \u201cAt the same time, patients, like other consumers, have largely been conditioned to expect frictionless, personalized and instantaneous service. We are very pleased to partner with MedQuest Associates to meet these demands, helping them deliver award-winning patient experiences with CXone.\u201d\n<\/p>\n

\nAbout NICE
\n
<\/b>With NICE (Nasdaq: NICE), it\u2019s never been easier for organizations of all sizes around the globe to create extraordinary customer experiences while meeting key business metrics. Featuring the world\u2019s #1 cloud native customer experience platform, CXone, NICE is a worldwide leader in AI-powered self-service and agent-assisted CX software for the contact center \u2013 and beyond. Over 25,000 organizations in more than 150 countries, including over 85 of the Fortune 100 companies, partner with NICE to transform – and elevate – every customer interaction. www.nice.com<\/a>\n<\/p>\n

\nTrademark Note:<\/i> NICE and the NICE logo are trademarks or registered trademarks of NICE Ltd. All other marks are trademarks of their respective owners. For a full list of NICE\u2019s marks, please see: www.nice.com\/nice-trademarks<\/a>.\n<\/p>\n

\nForward-Looking Statements
\n
<\/i><\/b>This press release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements, including the statements by <\/i>Mr. Jarman<\/i>, are based on the current beliefs, expectations and assumptions of the management of NICE Ltd. (the \u201cCompany\u201d). In some cases, such forward-looking statements can be identified by terms such as \u201cbelieve,\u201d \u201cexpect,\u201d \u201cseek,\u201d \u201cmay,\u201d \u201cwill,\u201d \u201cintend,\u201d \u201cshould,\u201d \u201cproject,\u201d \u201canticipate,\u201d \u201cplan,\u201d \u201cestimate,\u201d or similar words. Forward-looking statements are subject to a number of risks and uncertainties that could cause the actual results or performance of the Company to differ materially from those described herein, including but not limited to the impact of changes in economic and business conditions, including as a result of the COVID-19 pandemic; competition; successful execution of the Company\u2019s growth strategy; success and growth of the Company\u2019s cloud Software-as-a-Service business; changes in technology and market requirements; decline in demand for the Company’s products; inability to timely develop and introduce new technologies, products and applications; difficulties or delays in absorbing and integrating acquired operations, products, technologies and personnel; loss of market share; an inability to maintain certain marketing and distribution arrangements; the Company\u2019s dependency on third-party cloud computing platform providers, hosting facilities and service partners;, cyber security attacks or other security breaches against the Company; the effect of newly enacted or modified laws, regulation or standards on the Company and our products and various other factors and uncertainties discussed in our filings with the U.S. Securities and Exchange Commission (the \u201cSEC\u201d). For a more detailed description of the risk factors and uncertainties affecting the company, refer to the Company’s reports filed from time to time with the SEC, including the Company\u2019s Annual Report on Form 20-F. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company undertakes no obligation to update or revise them, except as required by law.<\/i>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nCorporate Media Contact<\/b>
Christopher Irwin-Dudek, +1 201 561 4442, chris.irwin-dudek@nice.com<\/a>, ET\n<\/p>\n

\nInvestors<\/b>
Marty Cohen, +1 551 256 5354, ir@nice.com<\/a>, ET
\n
Omri Arens, +972 3 763 0127, ir@nice.com<\/a>, CET\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

A leader in outpatient imaging services to provide smart digital and self-service experiences with NICE CXone to improve services for patients, health systems and hospitals HOBOKEN, N.J.–(BUSINESS WIRE)–#NICE—NICE (Nasdaq: NICE) today announced that MedQuest Associates, a leading manager of outpatient diagnostic imaging facilities, has selected the NICE CXone Essentials Suite to enrich its services to … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-44209","6":"format-standard","7":"category-industry"},"yoast_head":"\nNICE CXone Selected by MedQuest to Enhance Patient Experiences with New Advanced Integrated Digital and Self-Service - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/nice-cxone-selected-by-medquest-to-enhance-patient-experiences-with-new-advanced-integrated-digital-and-self-service\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NICE CXone Selected by MedQuest to Enhance Patient Experiences with New Advanced Integrated Digital and Self-Service - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"A leader in outpatient imaging services to provide smart digital and self-service experiences with NICE CXone to improve services for patients, health systems and hospitals HOBOKEN, N.J.–(BUSINESS WIRE)–#NICE—NICE (Nasdaq: NICE) today announced that MedQuest Associates, a leading manager of outpatient diagnostic imaging facilities, has selected the NICE CXone Essentials Suite to enrich its services to ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/nice-cxone-selected-by-medquest-to-enhance-patient-experiences-with-new-advanced-integrated-digital-and-self-service\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-23T12:01:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220523005082\/en\/1145221\/21\/NICE_Logo_New.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nice-cxone-selected-by-medquest-to-enhance-patient-experiences-with-new-advanced-integrated-digital-and-self-service\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nice-cxone-selected-by-medquest-to-enhance-patient-experiences-with-new-advanced-integrated-digital-and-self-service\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"NICE CXone Selected by MedQuest to Enhance Patient Experiences with New Advanced Integrated Digital and Self-Service\",\"datePublished\":\"2022-05-23T12:01:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nice-cxone-selected-by-medquest-to-enhance-patient-experiences-with-new-advanced-integrated-digital-and-self-service\\\/\"},\"wordCount\":1035,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nice-cxone-selected-by-medquest-to-enhance-patient-experiences-with-new-advanced-integrated-digital-and-self-service\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220523005082\\\/en\\\/1145221\\\/21\\\/NICE_Logo_New.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nice-cxone-selected-by-medquest-to-enhance-patient-experiences-with-new-advanced-integrated-digital-and-self-service\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nice-cxone-selected-by-medquest-to-enhance-patient-experiences-with-new-advanced-integrated-digital-and-self-service\\\/\",\"name\":\"NICE CXone Selected by MedQuest to Enhance Patient Experiences with New Advanced Integrated Digital and Self-Service - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nice-cxone-selected-by-medquest-to-enhance-patient-experiences-with-new-advanced-integrated-digital-and-self-service\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nice-cxone-selected-by-medquest-to-enhance-patient-experiences-with-new-advanced-integrated-digital-and-self-service\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220523005082\\\/en\\\/1145221\\\/21\\\/NICE_Logo_New.jpg\",\"datePublished\":\"2022-05-23T12:01:18+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nice-cxone-selected-by-medquest-to-enhance-patient-experiences-with-new-advanced-integrated-digital-and-self-service\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nice-cxone-selected-by-medquest-to-enhance-patient-experiences-with-new-advanced-integrated-digital-and-self-service\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nice-cxone-selected-by-medquest-to-enhance-patient-experiences-with-new-advanced-integrated-digital-and-self-service\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220523005082\\\/en\\\/1145221\\\/21\\\/NICE_Logo_New.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220523005082\\\/en\\\/1145221\\\/21\\\/NICE_Logo_New.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nice-cxone-selected-by-medquest-to-enhance-patient-experiences-with-new-advanced-integrated-digital-and-self-service\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NICE CXone Selected by MedQuest to Enhance Patient Experiences with New Advanced Integrated Digital and Self-Service\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NICE CXone Selected by MedQuest to Enhance Patient Experiences with New Advanced Integrated Digital and Self-Service - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/nice-cxone-selected-by-medquest-to-enhance-patient-experiences-with-new-advanced-integrated-digital-and-self-service\/","og_locale":"en_US","og_type":"article","og_title":"NICE CXone Selected by MedQuest to Enhance Patient Experiences with New Advanced Integrated Digital and Self-Service - Pharma Trend","og_description":"A leader in outpatient imaging services to provide smart digital and self-service experiences with NICE CXone to improve services for patients, health systems and hospitals HOBOKEN, N.J.–(BUSINESS WIRE)–#NICE—NICE (Nasdaq: NICE) today announced that MedQuest Associates, a leading manager of outpatient diagnostic imaging facilities, has selected the NICE CXone Essentials Suite to enrich its services to ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/nice-cxone-selected-by-medquest-to-enhance-patient-experiences-with-new-advanced-integrated-digital-and-self-service\/","og_site_name":"Pharma Trend","article_published_time":"2022-05-23T12:01:18+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220523005082\/en\/1145221\/21\/NICE_Logo_New.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/nice-cxone-selected-by-medquest-to-enhance-patient-experiences-with-new-advanced-integrated-digital-and-self-service\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/nice-cxone-selected-by-medquest-to-enhance-patient-experiences-with-new-advanced-integrated-digital-and-self-service\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"NICE CXone Selected by MedQuest to Enhance Patient Experiences with New Advanced Integrated Digital and Self-Service","datePublished":"2022-05-23T12:01:18+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/nice-cxone-selected-by-medquest-to-enhance-patient-experiences-with-new-advanced-integrated-digital-and-self-service\/"},"wordCount":1035,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/nice-cxone-selected-by-medquest-to-enhance-patient-experiences-with-new-advanced-integrated-digital-and-self-service\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220523005082\/en\/1145221\/21\/NICE_Logo_New.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/nice-cxone-selected-by-medquest-to-enhance-patient-experiences-with-new-advanced-integrated-digital-and-self-service\/","url":"https:\/\/pharma-trend.com\/en\/nice-cxone-selected-by-medquest-to-enhance-patient-experiences-with-new-advanced-integrated-digital-and-self-service\/","name":"NICE CXone Selected by MedQuest to Enhance Patient Experiences with New Advanced Integrated Digital and Self-Service - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/nice-cxone-selected-by-medquest-to-enhance-patient-experiences-with-new-advanced-integrated-digital-and-self-service\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/nice-cxone-selected-by-medquest-to-enhance-patient-experiences-with-new-advanced-integrated-digital-and-self-service\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220523005082\/en\/1145221\/21\/NICE_Logo_New.jpg","datePublished":"2022-05-23T12:01:18+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/nice-cxone-selected-by-medquest-to-enhance-patient-experiences-with-new-advanced-integrated-digital-and-self-service\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/nice-cxone-selected-by-medquest-to-enhance-patient-experiences-with-new-advanced-integrated-digital-and-self-service\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/nice-cxone-selected-by-medquest-to-enhance-patient-experiences-with-new-advanced-integrated-digital-and-self-service\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220523005082\/en\/1145221\/21\/NICE_Logo_New.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220523005082\/en\/1145221\/21\/NICE_Logo_New.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/nice-cxone-selected-by-medquest-to-enhance-patient-experiences-with-new-advanced-integrated-digital-and-self-service\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"NICE CXone Selected by MedQuest to Enhance Patient Experiences with New Advanced Integrated Digital and Self-Service"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44209","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44209"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44209\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44209"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44209"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44209"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}